Please login to the form below

Not currently logged in
Email:
Password:

Former Pfizer Incubator head joins Amarantus

Mark Benedyk previously led the Pfizer business in helping bring new medical innovations to patients

Amarantus BioScience has appointed Dr Mark Benedyk to its board of directors.

Dr Benedyk has served as a corporate adviser to the US-based biotech since 2011, supporting its research into conditions associated with neurodegeneration and apoptosis.

He currently serves as a managing partner at business consultancy Rila Partners in addition to being a member of the strategic advisory board at KemPharma and a director at the Center for Drug Research and Development Ventures.

Previous positions including serving as head of The Pfizer Incubator (TPI), a California-based business launched by Pfizer to help scientists with entrepreneurial ambitions to bring their medical innovations to patients.

Dr Benedyk has also held executive business development roles at Ascenta Therapeutics, Optimer Pharmaceuticals, Aurora Biosciences and Elan Pharmaceutical.

“I am excited to join the Amarantus board at such an important stage of the company's scientific and business development growth,” said Dr Benedyk.

“I look forward to helping the company as it advances MANF [mesencephalic astrocyte neurotrophic factor] towards the clinic for Parkinson's disease, and executes a commercial strategy for its promising clinical diagnostic tests for Parkinson's and Alzheimer's disease.”

21st March 2013

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Genetic Digital

We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics